MD4153151T2 - Plastrure medical cu eliberare lentă - Google Patents

Plastrure medical cu eliberare lentă

Info

Publication number
MD4153151T2
MD4153151T2 MDE20230333T MDE20230333T MD4153151T2 MD 4153151 T2 MD4153151 T2 MD 4153151T2 MD E20230333 T MDE20230333 T MD E20230333T MD E20230333 T MDE20230333 T MD E20230333T MD 4153151 T2 MD4153151 T2 MD 4153151T2
Authority
MD
Moldova
Prior art keywords
slow
release
patch based
medical patch
medical plaster
Prior art date
Application number
MDE20230333T
Other languages
English (en)
Inventor
Carlo Pizzocaro
Original Assignee
Fidia Farm Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fidia Farm Spa filed Critical Fidia Farm Spa
Publication of MD4153151T2 publication Critical patent/MD4153151T2/ro

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/196—Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Dermatology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Rheumatology (AREA)
  • Neurology (AREA)
  • Pain & Pain Management (AREA)
  • Inorganic Chemistry (AREA)
  • Immunology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Materials For Medical Uses (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Finger-Pressure Massage (AREA)

Abstract

Invenţia se referă la un plasture medical cu eliberare lentă, pe bază de diclofenac, în special un plasture medical pe bază de sare de sodiu de diclofenac, a cărei formulare permite eliberarea ingredientului activ în mod continuu şi la concentraţii active din punct de vedere terapeutic local timp de 24 de ore, precum şi la adezivul polimeric, matrice (PSA) pentru utilizare într-un plasture medical pe bază de sare de sodiu de diclofenac.
MDE20230333T 2020-05-20 2021-05-18 Plastrure medical cu eliberare lentă MD4153151T2 (ro)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT102020000011686A IT202000011686A1 (it) 2020-05-20 2020-05-20 Cerotto medicato a lento rilascio
PCT/IB2021/054261 WO2021234562A1 (en) 2020-05-20 2021-05-18 Slow-release medical plaster

Publications (1)

Publication Number Publication Date
MD4153151T2 true MD4153151T2 (ro) 2024-04-30

Family

ID=71994907

Family Applications (1)

Application Number Title Priority Date Filing Date
MDE20230333T MD4153151T2 (ro) 2020-05-20 2021-05-18 Plastrure medical cu eliberare lentă

Country Status (35)

Country Link
US (1) US20230190668A1 (ro)
EP (1) EP4153151B1 (ro)
KR (1) KR20230013033A (ro)
CN (1) CN115666537A (ro)
AR (1) AR122136A1 (ro)
AT (1) AT525409A3 (ro)
BE (1) BE1028251B1 (ro)
CA (1) CA3178964A1 (ro)
CH (1) CH718822B1 (ro)
CZ (1) CZ2022461A3 (ro)
DE (1) DE112021002871T5 (ro)
DK (2) DK4153151T3 (ro)
EE (1) EE05862B1 (ro)
ES (2) ES2936185R1 (ro)
FI (1) FI4153151T3 (ro)
FR (1) FR3110397A1 (ro)
GB (1) GB2610106A (ro)
GR (1) GR1010304B (ro)
HR (1) HRP20240192T1 (ro)
HU (1) HUP2200459A2 (ro)
IE (1) IE20210109A1 (ro)
IT (1) IT202000011686A1 (ro)
LT (1) LT4153151T (ro)
LU (1) LU501245B1 (ro)
MA (1) MA59594B1 (ro)
MD (1) MD4153151T2 (ro)
NL (1) NL2028233B1 (ro)
PL (2) PL4153151T3 (ro)
PT (1) PT4153151T (ro)
RO (1) RO137440A2 (ro)
RS (1) RS65194B1 (ro)
SI (1) SI4153151T1 (ro)
SK (1) SK500562022A3 (ro)
TR (1) TR2021008324A2 (ro)
WO (1) WO2021234562A1 (ro)

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH09208463A (ja) * 1996-02-07 1997-08-12 Tsumura & Co 経皮吸収性に優れた消炎鎮痛組成物
JP4181232B2 (ja) * 1997-07-18 2008-11-12 帝國製薬株式会社 ジクロフェナクナトリウム含有油性外用貼付製剤
JP4865958B2 (ja) * 2001-05-23 2012-02-01 株式会社トクホン 鎮痛抗炎症局所作用型の貼付剤
CN1215838C (zh) * 2003-06-25 2005-08-24 蚌埠丰原医药科技发展有限公司 双氯芬酸钠贴剂及其制备方法
TW200628175A (en) * 2004-10-08 2006-08-16 Noven Pharma Transdermal drug delivert device including an occlusive backing
DK1877509T3 (da) 2005-03-17 2012-01-23 Pharmafilm S R L Vandigt polymersystem til trykfølsom klæbemiddelmatrixfremstilling
US20070259029A1 (en) * 2006-05-08 2007-11-08 Mcentire Edward Enns Water-dispersible patch containing an active agent for dermal delivery
EA201390980A1 (ru) 2010-12-29 2013-11-29 Фармафилм С.Р.Л. Лекарственный пластырь для улучшенного трансдермального проникновения диклофенака диэтиламмония
WO2012160125A1 (en) * 2011-05-26 2012-11-29 Novartis Ag Compositions for percutaneous administration of physiologically active agents
PT2865378T (pt) * 2012-06-20 2018-01-15 Hisamitsu Pharmaceutical Co Adesivo para a pele
EP3206673A1 (en) 2014-10-17 2017-08-23 Fidia Farmaceutici S.p.A. Dermal therapeutic system with high adhesivity

Also Published As

Publication number Publication date
NL2028233A (en) 2021-12-01
PL442805A1 (pl) 2023-07-03
RS65194B1 (sr) 2024-03-29
WO2021234562A1 (en) 2021-11-25
FR3110397A1 (fr) 2021-11-26
EE05862B1 (et) 2024-01-15
SK500562022A3 (sk) 2022-12-21
GB2610106A (en) 2023-02-22
RO137440A2 (ro) 2023-05-30
IE20210109A1 (en) 2022-08-17
MA59594B1 (fr) 2024-03-29
LT4153151T (lt) 2024-02-26
GB202217015D0 (en) 2022-12-28
CN115666537A (zh) 2023-01-31
LU501245B1 (fr) 2022-05-17
FI4153151T3 (fi) 2024-02-08
ES2972189T3 (es) 2024-06-11
BE1028251B1 (fr) 2022-04-05
CH718822B1 (it) 2024-01-15
EP4153151A1 (en) 2023-03-29
DK202201037A1 (en) 2022-11-21
LU501245A1 (fr) 2022-02-15
CA3178964A1 (en) 2021-11-25
AR122136A1 (es) 2022-08-17
BE1028251A1 (fr) 2021-11-29
NL2028233B1 (en) 2023-10-25
DE112021002871T5 (de) 2023-03-23
PT4153151T (pt) 2024-02-05
EE202200014A (et) 2022-12-15
AT525409A2 (de) 2023-03-15
GR20210100319A (el) 2021-12-09
EP4153151B1 (en) 2023-11-22
US20230190668A1 (en) 2023-06-22
PL4153151T3 (pl) 2024-04-22
AT525409A3 (de) 2023-04-15
KR20230013033A (ko) 2023-01-26
HUP2200459A2 (hu) 2023-03-28
TR2021008324A2 (tr) 2021-12-21
IT202000011686A1 (it) 2021-11-20
ES2936185A2 (es) 2023-03-14
DK4153151T3 (da) 2024-02-05
SI4153151T1 (sl) 2024-03-29
ES2936185R1 (es) 2023-10-11
HRP20240192T1 (hr) 2024-05-10
CZ2022461A3 (cs) 2022-12-14
GR1010304B (el) 2022-09-28

Similar Documents

Publication Publication Date Title
UY30472A1 (es) Nuevos derivados de pirimidina, procesos para su preparacion composiciones farmacéuticas conteniédolos, procesos para su preparacion y aplicaciones.
IN2012MN02923A (ro)
CY1111713T1 (el) Συνθεση δισκιου εκτεταμενης απελευθερωσεως περιεχουσα πραμιπεξολη ή ενα φαρμακευτικα αποδεκτο αλας της, μεθοδος παραγωγης της και χρηση τους
MX2009009463A (es) Preparacion de una pelicula de rapida disolucion/desintegracion que tiene una alta proporcion de ingrediente activo.
BR112012018670A2 (pt) combinação, uso de um composto, composição farmacêutica, e, pacote de paciente
ATE554084T1 (de) N-hydroxyacrylamidverbindungen
EA200901423A1 (ru) Бензимидазолы и содержащие их фармацевтические композиции
BRPI0412999A (pt) 2-aminotetralina substituìda para tratamento de depressão
ATE503467T1 (de) Tablettierte atazanavirhaltige zusammensetzungen
EA202191239A1 (ru) Соединения и их применение для лечения дефицита 1-антитрипсина
MX2009013462A (es) Composiciones comprimidas que contienen atazanavir.
UY30393A1 (es) Derivados sustituidos de la 1-piperidin-1-il-1,3-dihidro-2h-benzimidazol-2-ona, composiciones farmacéuticas conteniéndolos, procesos de preparación y aplicaciones
EA201591338A1 (ru) Гастроретентивная лекарственная форма секвестранта желчных кислот с замедленным высвобождением для перорального применения
CY1115961T1 (el) Ανυδρη μορφη κρυσταλλικης μηλεϊνικης ορβεπιταντης (orvepitant maleate)
MY187899A (en) (2s,4r)-5-(5'-chloro-2'-fluorobiphenyl-4-yl)-4-(ethoxyoxalylamino)-2-hydroxymethyl-2-methylpentanoic acid as neprilysin inhibitor
ZA202006377B (en) Boronic acid derivatives and therapeutic uses thereof
DK2244703T3 (da) Lægemiddel og fremstillingen og anvendelse deraf i behandlingen af smertefulde neuropatier
MX2009013504A (es) Composiciones comprimidas que tienen atazanavir.
MX2012004082A (es) Inhibidores de cxcr1/2 como adyuvantes en el trasplante de islotes pancreaticos.
MD4153151T2 (ro) Plastrure medical cu eliberare lentă
EA201100287A1 (ru) Композиция ропинирола
RU2011103476A (ru) Нифуртимокс для лечения болезней, вызванных трихомонадидами
ATE500820T1 (de) Tablettierte atazanavirhaltige zusammensetzungen
EA200801003A1 (ru) Фармацевтически приемлемые соли и гидраты ризедроновой кислоты
RU2011111925A (ru) Мазь для лечения при укушенных ранах